Editorial: Single-domain antibodies—biology, engineering and emerging applications, volume II

Kevin A. Henry, Greg Hussack, Jan Gettemans, Cory L. Brooks · 2024

Read Editorial: Single-domain antibodies—biology, engineering and emerging applications, volume II by Kevin A. Henry, Greg Hussack, Jan Gettemans, Cory L. Brooks (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11687123.txt.

Description

Kevin A Henry and co-authors open a 2024 journal editorial introducing the second volume of a research collection on single-domain antibodies. These small binding proteins, first found in camelids and sharks, have moved from curiosity to clinic since the first volume in 2017. The editors survey that rise and frame the new set of papers.

An approved drug for a rare clotting disorder, strong antiviral results during the COVID-19 pandemic, and cell therapies built on these binders mark the field's growth. The volume holds twelve research articles and two reviews. Imaging and diagnostic uses stand out, often aimed at the pandemic virus, alongside work on basic binder properties.

Catalog record

CREATORKevin A. Henry, Greg Hussack, Jan Gettemans, Cory L. Brooks
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE11 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11687123

Browse the full library · About the Tower of Babel